ARTICLE | Clinical News
NovoTTF-100A System regulatory update
April 13, 2015 7:00 AM UTC
Japan approved Optune tumor treating fields ( TTFields) delivery device from Novocure to treat recurrent glioblastoma multiforme (GBM). Optune is a non-invasive portable device that disrupts the divis...